Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11976277 Particle delivery systems

Patent 11976277 was granted and assigned to Scribe Therapeutics on May, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Scribe Therapeutics
Scribe Therapeutics
0
Date Filed
February 3, 2023
0
Date of Patent
May 7, 2024
0
Patent Applicant
Scribe Therapeutics
Scribe Therapeutics
0
Patent Application Number
18164138
0
Patent Citations
‌
US Patent 11535835 Compositions and methods for the targeting of rhodopsin
0
‌
US Patent 11649264 Methods and products for genetic engineering
0
‌
US Patent 11560555 Engineered proteins
0
‌
US Patent 8920812 Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS
0
‌
US Patent 9322037 Cas9-FokI fusion proteins and uses thereof
0
‌
US Patent 10570415 RNA-guided nucleic acid modifying enzymes and methods of use thereof
0
‌
US Patent 10968253 Methods and products for genetic engineering
0
‌
US Patent 10988779 Viral delivery of RNA utilizing self-cleaving ribozymes and CRISPR-based applications thereof
0
Patent Inventor Names
Sean Higgins
0
Gayathri Vijayakumar
0
Trent Gomberg
0
Angus Sidore
0
Sarah Denny
0
Brett T. Staahl
0
Jason Fernandes
0
Isabel Colin
0
Matthew Gardner
0
Maroof Adil
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11976277
0
Patent Primary Examiner
‌
J. E. Angell
0
CPC Code
‌
C07K 14/005
0
‌
A61K 9/5052
0
‌
A61K 9/0019
0
‌
C12N 2320/32
0
‌
C12N 2310/3519
0
‌
C12N 2310/20
0
‌
C12N 2310/16
0
‌
C12N 9/22
0
‌
C12N 15/111
0

Find more entities like US Patent 11976277 Particle delivery systems

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.